Mohamed Elbahnasawy

InstitutionTanta University
AddressTanta
Egypt
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 4 Covid-19 publications, with a maximum of 3 publications in January 2021
    All Publications
    Bar chart showing 4 publications over 1 distinct years, with a maximum of 4 publications in 2021
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Abd-Elsalam S, Noor RA, Badawi R, Khalaf M, Esmail ES, Soliman S, Abd El Ghafar MS, Elbahnasawy M, Moustafa EF, Hassany SM, Medhat MA, Ramadan HK, Eldeen MAS, Alboraie M, Cordie A, Esmat G. Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study. J Med Virol. 2021 Oct; 93(10):5833-5838. PMID: 34076901.
      Citations: 7     Fields:    Translation:Humans
    2. Dabbous HM, Abd-Elsalam S, El-Sayed MH, Sherief AF, Ebeid FFS, El Ghafar MSA, Soliman S, Elbahnasawy M, Badawi R, Tageldin MA. Efficacy of favipiravir in COVID-19 treatment: a multi-center randomized study. Arch Virol. 2021 Mar; 166(3):949-954. PMID: 33492523.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    3. Zaky S, Metwally MA, El Badry M, Hasan AA, Abd-Elsalam S, El-Raey F, Eid A, Alboraie M, Elbahnasawy M, Elrefai AW, Elnaggar AA, Moustafa EF, Abdelaziz A, Baki AA, Elassal G, Abdelbary A, Abdalmohsen AS, Kamal E, Asem N, Ibrahim H, Taema K, Amin W, Kotb FM, Mohamed AS, Abdelmageed NA, Elnady M, Masoud HH, Hassany M, Zaid H. Utility of Lung Ultrasound in Decision-making to Prioritize Hospital Admission for COVID-19 Patients: A Developing Country Perspective. Curr Med Imaging. 2021; 17(12):1473-1480. PMID: 33966621.
      Citations:    Translation:Humans
    4. Abd-Elsalam S, Esmail ES, Khalaf M, El-Sarnagawy GN, Shalaby SM, Abd El Ghafar MS, Elbahnasawy M, Elfert A, Soliman H, El-Kalla F, Ghoneim A. Tanta Protocol for Management of COVID-19: Perspectives from a Developing Country. Endocr Metab Immune Disord Drug Targets. 2021; 21(10):1775-1780. PMID: 33208083.
      Citations: 1     Fields:    Translation:Humans